BioProcess International Europe

The event is designed to bridge cutting-edge science with implementation-ready strategies, helping teams accelerate scale-up, improve robustness and adopt data-driven approaches to modern biomanufacturing.

Who the audience is and how many attend

Audience

• Biopharma and biotech process development teams (upstream, downstream and analytical)
• Manufacturing, MSAT and technical operations leaders responsible for scale-up and tech transfer
• Cell line development and expression engineering specialists
• ATMP (cell & gene therapy) development and manufacturing professionals
• Digital manufacturing, data/AI, automation and PAT teams
• CDMOs and bioprocessing technology and service providers

Scale

• Format: Conference + exhibition
• Programme structure: 5 main conference tracks and 4 pre-conference workshops
• The organiser does not consistently publish a single fixed headline figure for total attendees/exhibitors on the main overview pages.

What to expect

• Four days of bioprocessing content covering cell line engineering, upstream intensification, downstream innovation, ATMP manufacturing and digital/AI-enabled operations
• Pre-conference workshops plus a multi-track main agenda built around practical, implementation-focused learning
• An exhibition environment for meeting technology providers across the bioprocessing toolchain
• High-density networking with scientists, innovators and manufacturing leaders working on biologics and advanced modalities